Overview

An Investigational Drug in Patients With Osteoarthritis (0663-073)

Status:
Completed
Trial end date:
2003-11-13
Target enrollment:
Participant gender:
Summary
This study was conducted to assess the safety and tolerability of an investigational drug and to evaluate its effectiveness in the treatment of osteoarthritis of the hip or knee in both men and women.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Etoricoxib
Ibuprofen